{"id":"W2145879538","doi":"10.1016/j.biomaterials.2013.07.068","title":"Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Biomaterials","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; Canadian Institutes of Health Research; National Institutes of Health; Alberta Cancer Foundation","keywords":"CD30; Anaplastic large-cell lymphoma; Doxorubicin; Medicine; Cancer research; Liposome; Lymphoma; Antibody; Monoclonal antibody; Brentuximab vedotin; Pharmacology; Chemotherapy; Immunology; Chemistry; Internal medicine; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010954,0.0002458763,0.000177569,0.0001386312,0.00008238789,0.0001543055,0.0001319765,0.0002136456,0.000805088],"category_scores_gemma":[0.0000747282,0.0001019148,0.0001021608,0.00009998932,0.000120463,0.0001860078,0.0001256455,0.000246748,0.0002034592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001899935,"about_ca_system_score_gemma":0.0001805101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004882393,"about_ca_topic_score_gemma":0.0007860299,"domain_scores_codex":[0.9999485,0.000007495594,0.000003990675,0.00001026319,0.00001326799,0.00001657732],"domain_scores_gemma":[0.9999696,0.000005838009,0.000007243478,0.000003216334,0.000004441649,0.000009684445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001953632,0.00005001933,0.0000641478,0.00003659098,0.000004340231,0.00004905267,0.000008990836,0.0001226359,0.9958507,0.000118666,0.00009297638,0.00340646],"study_design_scores_gemma":[0.0000909769,0.001015809,0.001855947,0.000003545135,0.00003589807,0.0003194082,0.000008215563,0.001401801,0.9924925,0.00003653094,0.002732344,0.0000070903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946545,0.001832543,0.001856627,0.00007175768,0.00004257036,0.00003021041,0.00007426833,0.00006182714,0.001375704],"genre_scores_gemma":[0.9970101,0.0006819729,0.000930498,0.00002978281,0.000007364173,0.00001663507,0.00007877481,0.000007710494,0.001237109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000805088,"threshold_uncertainty_score":0.002693236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007358194956652742,"score_gpt":0.2324224090353347,"score_spread":0.2250642140786819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}